Methylene blue modulates mitochondrial electron flow via multiple regulatory sites in isolated brain mitochondria: Implications for neurodegeneration (2026)

Peer-Reviewed Study · Zdeněk Fišar, Karolína Škutová, Jana Hroudová · September 30, 2026

Zdeněk Fišar et al., 2026-09-30: Isolated brain mitochondria dose-response showing that a low 1 micromol/L concentration did not raise oxygen consumption but did raise hydrogen peroxide production, while higher concentrations inhibited complex II- and IV-linked respiration.

Low-dose MB (1 μmol/L) did not alter oxygen flux or flux control ratios across SUIT-defined respiratory states but significantly increased H₂O₂ production and the H₂O₂/O₂ flux ratio prior to inhibitor addition.

Abstract

Zdeněk Fišar et al., 2026-09-30: Isolated brain mitochondria dose-response showing that a low 1 micromol/L concentration did not raise oxygen consumption but did raise hydrogen peroxide production, while higher concentrations inhibited complex II- and IV-linked respiration. Laboratory study, isolated brain mitochondria with high-resolution respirometry and fluorescence H2O2 detection. Country: Czech Republic (Charles University, Prague). Concentrations: 1, 5 and 10 micromol/L; EC50 2.2 micromol/L (complex I-linked respiration), IC50 0.57 micromol/L (complex II-linked), EC50 7.1 micromol/L (rotenone-inhibited complex I-linked). Route: in vitro. Funder: not stated in the record. Conflicts: 'The authors declare that they have no competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.' Comparator: mitochondria without MB. Bearing PARTLY SUPPORTS: it confirms the high-concentration half of the claim (complex II- and IV-linked respiration inhibited, ROS generated) and refutes the low-concentration half – at 1 micromol/L there was no change in oxygen flux but a significant rise in H2O2/ROS, i.e. the pro-oxidant effect appears at a concentration below the respiratory effect. Recorded at full strength because it is the most recent and most quantitative test of the low-dose claim. Also filed as MTJ-11 (claims C2, C3). Study type: lab.